What type of antibiotic (abx) is Flagyl (metronidazole)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Flagyl (Metronidazole) Classification

Flagyl (metronidazole) is a nitroimidazole antibiotic with selective activity against anaerobic bacteria and certain protozoa. 1, 2

Antimicrobial Spectrum

Anaerobic Bacterial Coverage

  • Metronidazole is bactericidal against most obligate anaerobic bacteria, including Gram-negative anaerobes (Bacteroides species including B. fragilis group, Fusobacterium species) and Gram-positive anaerobes (Clostridium species, Peptostreptococcus species, Peptococcus niger) 1, 2
  • It is considered the most active agent available against Bacteroides fragilis, the most resistant anaerobic pathogen, achieving bactericidal activity at low concentrations (MIC ≤1 mcg/mL for most strains) 1, 3
  • Kill-curve studies demonstrate a 2-5 log decrease in colony forming units within one hour of exposure 3

Protozoal Coverage

  • Metronidazole possesses direct trichomonacidal and amebacidal activity against Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia 1, 2
  • The CDC recommends metronidazole as the only oral medication available in the United States for treating trichomoniasis, with cure rates of 90-95% 4

Important Limitations

  • Metronidazole has NO clinically relevant activity against facultative anaerobes or obligate aerobes 1, 3
  • Resistant anaerobes include occasional anaerobic cocci, some non-sporulating Gram-positive bacilli, and Propionibacterium species 3
  • Must be combined with other agents (typically aminoglycosides or cephalosporins) when treating mixed aerobic-anaerobic infections 3, 5

Clinical Applications in Guidelines

Anaerobic Infections

  • Recommended for necrotizing fasciitis (ceftriaxone + metronidazole, with or without vancomycin) 6
  • Essential for anaerobic coverage in animal bites (combined with beta-lactams) 6
  • Key component for surgical site infections involving intestinal or genitourinary tract (combined with ceftriaxone or fluoroquinolones) 6
  • Used in intra-abdominal infections requiring anaerobic coverage, typically combined with agents covering aerobic Gram-negatives 6

Protozoal Infections

  • First-line treatment for Giardia lamblia (alternative to tinidazole) 6
  • Treatment for Clostridium difficile infection as a second-line agent when vancomycin or fidaxomicin cannot be obtained 6
  • Preferred treatment for trichomoniasis with metronidazole 500 mg twice daily for 7 days or 2g single dose 4, 7

Mechanism and Pharmacology

  • Metronidazole is a 5-nitroimidazole compound that requires reduction by anaerobic organisms to become active 2, 8
  • Peak plasma concentrations occur 1-2 hours after oral administration, with excellent tissue penetration including cerebrospinal fluid, saliva, and abscesses 1, 5
  • Approximately 20% of circulating metronidazole is bound to plasma proteins, with an elimination half-life of 8 hours 1

Critical Pitfall to Avoid

Never use metronidazole vaginal gel for trichomoniasis—it achieves <50% efficacy and is only FDA-approved for bacterial vaginosis, not systemic protozoal infections 4, 7

References

Guideline

Trichomoniasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Trichomonas Urethritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metronidazole.

Mayo Clinic proceedings, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.